-
0.92025 Impact Factor
-
1.82025 CiteScore
Editor-in-Chief
Takao Fujii
Editorial Board
Reasons to publish in Modern Rheumatology Case Reports
Discover the author benefits available when you publish your article with Modern Rheumatology Case Reports.
Learn more
Interested in publishing with us?
Learn more about the Modern Rheumatology Case Reports submission process and requirements.
Find out more

High Impact Articles
Discover the most read and cited research published in Modern Rheumatology Case Reports in recent years and read the papers making an impact in the field of rheumatology.
Start reading
Email Alerts
Keep up to date by registering to receive email alerts. Our alerting services allow you to be informed when Modern Rheumatology Case Reports content publishes and can be tailored to suit your needs.
Register Now
About the Japanese College of Rheumatology
The Japanese College of Rheumatology is made up of over 10,000 practicing physicians, research scientists and academic scholars across Japan, dedicated to reducing the burden of rheumatic diseases on individuals and societies.
Find out more
The pathophysiology of organ involvement in eosinophilic granulomatosis with polyangiitis is characterised by vasculitis and eosinophilic inflammation, which can be accompanied by eosinophil extracellular trap cell death (EETosis). Clinically, eosinophilic inflammation is often observed in the ...
Primary erythromelalgia (PEM) is a rare autosomal dominant disorder characterised by episodic erythema and burning pain of the extremities, typically triggered by exercise or fatigue. PEM usually begins in childhood and is caused by gain-of-function variants in SCN9A, which encodes the ...
Granulomatosis with polyangiitis (GPA) is a subtype of antineutrophilic cytoplasmic antibodies-associated vasculitis that can have a heterogeneous clinical presentation. Although classically involving the respiratory tract and kidneys, GPA can rarely present with predominant skeletal muscle ...
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare necrotising vasculitis affecting small vessels accompanied by eosinophilic inflammation. Biological therapies, particularly anti-interleukin-5 (IL-5) monoclonal antibodies, have been shown to be effective in treating refractory EGPA. Mepolizumab, an anti-IL-5 ...
The recombinant zoster vaccine (RZV) is immunologically and clinically effective in immunosuppressed patients. Though rheumatoid arthritis (RA) and the Janus kinase inhibitor (JAKi) increase the risk of herpes zoster (HZ) infection, breakthrough cases in which a HZ infection followed RZV administration are rare. We report ...
Familial Mediterranean fever (FMF) is an autoinflammatory disease associated with mutations in MEFV , which encodes pyrin. Patients with FMF present intermittent high fever with elevated inflammatory markers during periodic attacks. While some forms of vasculitis, including immunoglobulin A (IgA) vasculitis and ...
The safety of belimumab during pregnancy, particularly in the third trimester, remains unclear. This study aimed to assess the placental and breast milk transfer of belimumab in pregnancies complicated by systemic lupus erythematosus and to evaluate immunological effects and vaccination responses in offspring. We ...
Microscopic polyangiitis (MPA) is an antineutrophil cytoplasmic antibody-associated vasculitis characterised by inflammation in small vessels. Avacopan, an oral C5a receptor inhibitor, has demonstrated efficacy in inducing and sustaining remission in MPA, with the added benefit of reducing glucocorticoid exposure and ...